Literature DB >> 9878843

Indole-3-propionate: a potent hydroxyl radical scavenger in rat brain.

B Poeggeler1, M A Pappolla, R Hardeland, A Rassoulpour, P S Hodgkins, P Guidetti, R Schwarcz.   

Abstract

The hydroxyl radical scavenging activity of indole-3-propionate was evaluated by kinetic competition studies with the hydroxyl radical trapping reagent 2,2'-azino-bis-(3-ethyl-benz-thiazoline-6-sulfonic acid) (ABTS) and by measuring hydroxyl radical-initiated lipid peroxidation in the rat striatum. Using ABTS, the indole was shown to act as a potent hydroxyl radical scavenger with a rate constant of 7.8x1010 mol l-1 s-1. Hydroxyl radical-initiated lipid peroxidation, determined by measuring tissue malondialdehyde formation, was inhibited dose-dependently both in vitro and in vivo. Indole-3-propionate reacts with hydroxyl radicals at a diffusion controlled rate and can thereby provide on-site protection against the oxidative damage of biomolecules induced by these highly reactive and toxic oxygen intermediates. While it remains to be established if endogenous brain tissue levels of indole-3-propionate are sufficiently high to have a significant impact on total antioxidative capacity, the compound itself or a structurally related agent may be useful as an antioxidant adjuvant to combat hydroxyl radical-mediated oxidative stress. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9878843     DOI: 10.1016/s0006-8993(98)01027-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  21 in total

1.  Sugar rush: Glucosylation of IPyA attenuates auxin levels.

Authors:  Arielle L Homayouni; Lucia C Strader
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-19       Impact factor: 11.205

2.  Carcinogen-induced, free radical-mediated reduction in microsomal membrane fluidity: reversal by indole-3-propionic acid.

Authors:  M Karbownik; J J Garcia; A Lewiński; R J Reiter
Journal:  J Bioenerg Biomembr       Date:  2001-02       Impact factor: 2.945

3.  Methyl Donor Deficiency Blocks Colorectal Cancer Development by Affecting Key Metabolic Pathways.

Authors:  Matthew P Hanley; Oladimeji Aladelokun; Krishna Kadaveru; Daniel W Rosenberg
Journal:  Cancer Prev Res (Phila)       Date:  2019-11-20

4.  Metabolomic distinction and insights into the pathogenesis of human primary dilated cardiomyopathy.

Authors:  Danny Alexander; Raffaella Lombardi; Gabriela Rodriguez; Matthew M Mitchell; Ali J Marian
Journal:  Eur J Clin Invest       Date:  2010-12-14       Impact factor: 4.686

5.  Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity.

Authors:  B Poeggeler; A Rassoulpour; H-Q Wu; P Guidetti; R C Roberts; R Schwarcz
Journal:  Neuroscience       Date:  2007-07-16       Impact factor: 3.590

Review 6.  Development of indole-3-propionic acid (OXIGON) for Alzheimer's disease.

Authors:  Paul E Bendheim; Burkhard Poeggeler; Eyal Neria; Vivi Ziv; Miguel A Pappolla; Daniel G Chain
Journal:  J Mol Neurosci       Date:  2002 Aug-Oct       Impact factor: 3.444

7.  Oxidative damage to macromolecules in the thyroid - experimental evidence.

Authors:  Małgorzata Karbownik-Lewińska; Agnieszka Kokoszko-Bilska
Journal:  Thyroid Res       Date:  2012-12-27

8.  Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value.

Authors:  Venkatramanujam Srinivasan; Charanjit Kaur; Seithikurippu Pandi-Perumal; Gregory M Brown; Daniel P Cardinali
Journal:  Int J Alzheimers Dis       Date:  2010-12-08

9.  Melatonin in Alzheimer's disease and other neurodegenerative disorders.

Authors:  V Srinivasan; S R Pandi-Perumal; D P Cardinali; B Poeggeler; R Hardeland
Journal:  Behav Brain Funct       Date:  2006-05-04       Impact factor: 3.759

10.  Coordination of auxin and ethylene biosynthesis by the aminotransferase VAS1.

Authors:  Zuyu Zheng; Yongxia Guo; Ondřej Novák; Xinhua Dai; Yunde Zhao; Karin Ljung; Joseph P Noel; Joanne Chory
Journal:  Nat Chem Biol       Date:  2013-02-03       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.